Latest Developments in Immunotherapy for Mesothelioma
Discover the latest immunotherapy treatments for mesothelioma patients. Get real-life insights from a top mesothelioma specialist and a panel of mesothelioma survivors who have successfully utilized immunotherapy to beat the odds.
Discover the latest immunotherapy treatments for mesothelioma patients. Get real-life insights from a top mesothelioma specialist and a panel of mesothelioma survivors who have successfully utilized immunotherapy to beat the odds.
-
J. Marie Suga, MDMedical Oncologist & Mesothelioma Specialist -
Michael ColePleural Mesothelioma Survivor -
Randy DerouenPeritoneal Mesothelioma Survivor -
Ron GreenPleural Mesothelioma Survivor
What You’ll Learn During the Webinar
Medical oncologist Dr. J. Marie Suga discusses the latest developments in treating mesothelioma with immunotherapy, while a panel of survivors share their experiences with immunotherapy and tips for those considering this type of treatment. Topics include:
- Top immunotherapy treatments available for mesothelioma
- New developments & advances in treatment
- Differences between immunotherapy & chemotherapy
- What to expect during immunotherapy treatment
- Insights from real mesothelioma survivors on the physical & mental effects associated with immunotherapy treatment
- Empowering stories from survivors who have successfully battled mesothelioma with the help of immunotherapy
You’ll also receive access to the free Q&A session our experts hosted during the event.
Hear From a Top Mesothelioma Specialist & Three Survivors
Medical oncologist Dr. J. Marie Suga and registered nurse Sean Marchese have spent years helping mesothelioma patients and their families. Survivors Michael Cole, Randy Derouen and Ron Green have walked in your shoes and know what it means to be a mesothelioma survivor.-
J. Marie Suga, MDAs an oncologist at Kaiser Permanente Vallejo Medical Center in California, Dr. J. Marie Suga serves as the medical director for the Kaiser Permanente Clinical Trials Program. She specializes in treating patients with lung cancer, breast cancer, colorectal cancer and malignant pleural mesothelioma. -
Michael ColeDiagnosed with pleural mesothelioma in 2015, Michael Cole opted for aggressive treatment. Initially, he underwent an extrapleural pneumonectomy and several rounds of chemotherapy. After a recurrence in 2018, he opted for immunotherapy and radiation. Since then, he has had only slow tumor changes and no new growth. -
Randy DerouenRandy Derouen was diagnosed with peritoneal mesothelioma in 2020. Because he was ineligible for surgery, Randy underwent months of chemotherapy, including heated intraperitoneal chemotherapy (HIPEC), and immunotherapy (Opdivo and Yervoy). For the last year, his PET scans have shown no evidence of growth. -
Ron GreenSince his 2016 pleural mesothelioma diagnosis, Ron Green participated in two clinical trials utilizing immunotherapies such as Keytruda (pembrolizumab) and anetumab ravtansine. Both worked well for him! For the last two years, he has been on the FDA-approved immunotherapy combination of Opdivo and Yervoy. -
Sean Marchese, MS, RNSean Marchese, MS, RN, has planned and led oncology clinical trials involving immunotherapy, chemotherapy, radiation therapy and tumor treating fields. He is a registered nurse with more than 10 years of clinical experience and more than six years of clinical research. Sean has been a member of the American Nurses Association since 2017.
Disclaimer: The content of this website is not intended as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician about questions you may have regarding your medical condition.
